April 18th, 2014
Would you pay someone to leave your company? Not severance or a buyout, but a check for anyone who simply wants to leave? Crazy talk? Yes, crazy like a fox.
Zappos started this whole thing years ago when it offered to pay new workers who wanted out $100, then $500, and now a full month’s salary. When the wily, if wacky, shoe and apparel company was bought by Amazon for a cool billion, the culture and the pay to quit program came with it. Read the rest of this entry »
April 17th, 2014
Patients made more use of the nation’s healthcare system in 2013, increasing their spending on drugs and making more visits to specialists and hospitals for outpatient treatment.
It’s the first time in three years that healthcare utilization has risen, says the IMS Institute for Healthcare Informatics. The Institute’s study, Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medicines in the United States in 2013, was released this week.
According to the study, Americans spent $329.2 billion on medicine last year, a 3.2% increase from 2012. The study attributes the increase fewer patent expirations (which allow lower priced generics to be sold), price increases, new medicines, and more doctor and hospital visits. Read the rest of this entry »
April 16th, 2014
A quick search on Google will give you tens of thousands of pages — and hundreds of videos, too — of help with interview questions.
Spend a little time reviewing the interview tips there and you’ll soon discover that when it comes to that favorite trap question — “What is your greatest weakness” — the conventional wisdom is to say something like “I work too hard” or to offer up a weakness that is non-essential to the job, such as “I get tense if I have to speak in front of a group.” Read the rest of this entry »
April 15th, 2014
No manager wants to be thought of as a poor leader, but how do you know if you are a good one?
Psychologist Kathryn Cramer, author of Lead Positive: What Highly Effective Leaders See, Say, and Do, says every leader has a “signature presence,” characteristics that define their style and are uniquely theirs. Biology makes us look first for problems than opportunities, a handicap that good leaders learn to overcome. Read the rest of this entry »
April 14th, 2014
The employment market for in-house counsel is improving as companies beef-up their legal departments. The trend is driven by both an improving economy and the desire to save on the cost of having outside counsel handle routine matters.
That’s heating up the market for attorneys, say John Okray and Diana Lai, chair and treasurer, respectively, of the Federal Bar Association Corporate and Association Counsel Division. “Whereas just a couple years ago, candidates were managing only one offer at time, now we see strong candidates with multiple offers at any given time,” they said in an interview published in Federal Lawyer. Read the rest of this entry »
April 10th, 2014
Young, small hedge funds outperformed their elders over the last 11 years, says data provider eVestment.
Indexing funds into three groups — up to two years, 2-5 years, and older funds — eVestment found the younger funds outperformed the other two groups in each study year. Read the rest of this entry »
April 9th, 2014
Back in the fifties, A.J. Liebling derisively called Chicago America’s Second City (in an article for, what else, The New Yorker). Today’s Chicagoland denizens have adopted it as a point of pride, right up there with the other unofficial motto, “The Windy City.”
Don’t be fooled into thinking, though, there’s anything second rate about this big, exciting, and urbane metropolis. Though Los Angeles has usurped Chicago’s long claim to being America’s second most populous city, the city still comes out ahead in so many ways. Read the rest of this entry »
April 8th, 2014
Whether palbociclib turns it to be the blockbuster The New York Times says it could be, the breast cancer drug created a stir this weekend at the annual meeting of the American Association for Cancer Research.
Developed by Pfizer, the drug’s stage II clinical trials are so promising in slowing the advance of breast cancer that one leading physician described them as “strikingly positive.” Dr. Jose Baselga, physician in chief at the Memorial Sloan-Kettering Cancer Center, who lead a discussion of the results, said that if the more rigorous phase 3 trials confirm the early results, then “they could represent a new standard in the therapy of patients.” Read the rest of this entry »
April 7th, 2014
This is crunch week at accounting firms across the U.S. With the clock tick-tocking down to April 15th, lights will be burning late into the night — and in more than a few places, won’t be shut off at all.
At this point, there’s not much you can do about the late hours and the unhealthy lack of sleep. One thing you can do this week is to reject all the junk food and high carb, high fat foods that get ordered in for lunch and dinner. Read the rest of this entry »
April 4th, 2014
This year, U.S. colleges will graduate somewhere around 124,000 information technology majors
Most of them will head straight into the workforce where the average starting salary for these new grads averages $59,000. Those with masters and PhDs, and those in high demand specialties like security, will earn much more. Read the rest of this entry »